Lipiodol: victory for the specialty
Lipiodol will no longer leave the Brazilian market. After two years of struggle, the National Health Surveillance Agency (Anvisa), the Ministry of Health, the Ministry of Education, the Ministry of Finance and a few other Secretariats and Technical Chambers approved the change in indication for the use of Lipiodol after its suitability for the market. By the number of approvals required, … Continue lendo